Outreach Signals
Publishing Details
Contact & Outreach
About This Podcast
Podcasting 2.0 Features
Social Media
Explore Statistics
Recent Episodes
S4E9 Rewriting the Rules of Medicine: Nir Barzilai on Targeting the Biology of Aging
In this episode, I talked to Dr. Nir Barzilai, the founding director of the Institute for Aging Research, on longevity, GLP-1 potentially treating aging, genetics of longevity, Trump's new food…
S4E8 Pharma Superintelligence: Dr. Alex Zhavoronkov’s Vision for Small Molecules
In this episode, I talked to Dr. Alex Zhavoronkov, CEO of Insilico Medicine, about using AI to generate small molecules for future drugs/therapies, pharma superintelligence, automation of drug…
S4E7 CRISPR T-Cells: Programming the Future of Medicine with Dr. Alexander Marson
In this episode, I talked to Dr. Alexander Marson, cofounder of Arsenal Biosciences and director of the Gladstone-UCSF Institute of Genomic Immunology. He is one of the pioneers of non-viral T-cell…
S4E6 Building Matter from the Bottom Up: Dr. Samuel Stupp on Supramolecular Self-Assembly"
In this episode, I talked to Dr. Samuel Stupp, Board of Trustees Professor of Materials Science, Chemistry, and Medicine at Northwestern University. He is one of the pioneers of supramolecular…
S4E5 A Deep Dive into the Intersection of Cardiac Research and Entrepreneurship
In this episode, I talked to Dr. Leslie Leinwand, Chief Scientific Officer of the BioFrontiers Institute at the University of Colorado Boulder and serial entrepreneur. In addition to her lab, she is…
S4E4 The Future of Drug Development: 3D Vascularized Tissue Models in Clinical Trials
In this episode, I talked to Dr. Karolina Valente, CEO of Voxcell BioInnovation. Dr. Valente talks about how her company, Voxcell, is trying to revolutionize the drug development process by…
S4E3 Dissecting the Gene Therapy Landscape: A Conversation with Dr. David Schaffer
In this episode, I talked to Dr. David Schaffer, director of the Bakar Labs at UC Berkeley and cofounder of publicly-trade biotech caleld 4D Molecular Therapeutics. We talked about different topics…
S4E2 The Everly Health Shark Tank Story: A Chat with Dr. Liz Kwo
I got the opportunity to talk to Dr. Liz Kwo, Chief Commercial Officer at Everly Health, Board member of Walmart Mexico, and experienced venture capitalist and angel investor. We talked about running…
S4E1 Maximizing Wound Healing: The Immunoengineering Approach ft. Dr Jennifer Elisseeff
I got the opportunity to talk to Dr. Jennifer Elisseeff, Morton Goldberg Professor and Director of the Translational Tissue Engineering Center at Johns Hopkins University and experienced…
S3E15 Unlocking the Venture Capital Puzzle: A Chat with Michael Langer
I got the opportunity to talk to Michael Langer, a well-known venture capitalist and investor in the biotech and health care industry, who is also the son of Moderna cofounder, Dr. Robert Langer. We…
S3E14 Navigating the World of Biotech Investments and Entrepreneurship ft. Dr. Michael Deem
I got the opportunity to talk to Dr. Michael Deem, a former bioengineering department chair at Rice, entrepreneur, and experienced venture capitalist. We talked about the similarities and differences…
S3E13 Entrepreneurship and Targeted Drug Therapy: Leveraging Receptor Science ft Dr. Joseph Schlessinger
I got the opportunity to talk to Dr. Joseph Schlessinger, professor at Yale and cofounder of SUGEN and Plexxikon. We talked about his experience as a captain the Israeli Army during the Six Day War…
S3E12 A Deep Dive into Nerve Graft Innovation and Biocompatibility ft. Dr. Christine E. Schmidt
I got the opportunity to talk to Dr. Christina Schmidt, professor at the Universit of Florida and inventor of the Avanca Nerve Graft. We talked about a lot of things from how she adapted to different…
S3E11 Key Advice by a Health Expert on Longevity, ft. Dr. Eric Verdin
I got the opportunity to talk to Dr. Eric Verdin, CEO of Buck Institute and an accomplished entrepreneur. We also talked about health advice for longevity, the supplement industry, beef between Dr…
S3E10 Science and Sustainability: A Conversation with Nobel Prize Winner, Dr. Peter C. Doherty
I got the opportunity to talk to Dr. Peter C. Doherty, the 1996 Nobel Prize winner in Physiology or Medicine. He is an internationally recognized scientist in immunology, and now scientific…
S3E9 Nobel Prize Winner Explores the Secrets of Green Fluorescence Proteins ft. Dr. Martin Chalfie
I got the opportunity to talk to Dr. Martin Chalfie, 2008 Nobel Prize Winner in Chemistry. He is an internationally recognized scientist in green fluorescence proteins, C elegans, and touch nerve…
S3E8 The Future of Fitness: Wearable Tech and the Revolution of Sweat Patches ft. Dr. Roozbeh Ghaffari
I got the opportunity to talk to Dr. Roozbeh Ghaffari, experienced entrepreneur and CEO of Epicore Biosystems. We talked about his new wearable tech company called Epicore Biosystems that tracks…
S3E7 The Truth About Anti-Aging: Expert Weighs In on the Science and Claims ft. Dr. Charles Brenner
I got the opportunity to talk to Dr. Charles Brenner, an expert in aging research and Alfred E Mann Family Foundation Chair of the Department of Diabetes & Cancer Metabolism at the Beckman…
S3E6 The Billion-Dollar Journey of a Scientific Pioneer ft. Dr. Robert Tjian
I got the opportunity to talk to Dr. Robert Tjian, former President of the Howard Hughes Medical Institute, about how Amygen acquired his startup, Tularik, for more than a billion dollars, venture…
S3E5 Uncovering the Nobel Prize-Winning Research on Hepatitis C and B ft. Dr. Charles M. Rice
I got the opportunity to talk to Dr. Charles M. Rice, Rockefeller University professor and 2020 Nobel Prize in Physiology or Medicine, about Hepatitis C and B, Covid-19 virus research, RNA viruses,…
Frequently Asked Questions
DG Early-Morning Show has published 54 episodes since June 2021, covering topics in Science.
DG Early-Morning Show is currently active with new episodes monthly. Average episode length is 51m.
Sign up on Grep.FM to access contact details for DG Early-Morning Show, including email and social media links.
